2018
DOI: 10.3390/ijms19071882
|View full text |Cite
|
Sign up to set email alerts
|

Glutathione in Ovarian Cancer: A Double-Edged Sword

Abstract: Glutathione (GSH) has several roles in a cell, such as a reactive oxygen species (ROS) scavenger, an intervenient in xenobiotics metabolism and a reservoir of cysteine. All of these activities are important in the maintenance of normal cells homeostasis but can also constitute an advantage for cancer cells, allowing disease progression and resistance to therapy. Ovarian cancer is the major cause of death from gynaecologic disease and the second most common gynaecologic malignancy worldwide. In over 50 years, t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
67
0
1

Year Published

2018
2018
2024
2024

Publication Types

Select...
9

Relationship

2
7

Authors

Journals

citations
Cited by 84 publications
(69 citation statements)
references
References 112 publications
(139 reference statements)
1
67
0
1
Order By: Relevance
“…The determination of dynamic radical changes in cellular microenvironment with non-invasive approaches is an essential mean for assessing the effectiveness of anticancer agents on cancer treatment [45][46][47][48]. As mentioned above, 5-FU's chemotherapeutic properties are attributed to thymidylate synthase (TS) activity inhibition, to mitochondrial ROS generation and the caspases cascade activation [49].…”
Section: Discussionmentioning
confidence: 99%
“…The determination of dynamic radical changes in cellular microenvironment with non-invasive approaches is an essential mean for assessing the effectiveness of anticancer agents on cancer treatment [45][46][47][48]. As mentioned above, 5-FU's chemotherapeutic properties are attributed to thymidylate synthase (TS) activity inhibition, to mitochondrial ROS generation and the caspases cascade activation [49].…”
Section: Discussionmentioning
confidence: 99%
“…Similarly, GSH plays an important role in cancer progression and resistance to therapy. Indeed, it is reported to be associated with chemoresistance to platinum salts, which is one of the main treatments for ovarian cancer [10]. Myo-inositol and phosphocholine (ChoP) have been reported in SKOV3 cells and their cellular concentrations reduced after treatment of Ptac2S, a novel anticancer agent [11].…”
Section: Discussionmentioning
confidence: 99%
“…This glutamine consumer phenotype may also be linked to cyst(e)ine dependency, as xCT concomitantly exports glutamate and imports cyst(e)ine. Glutamate is a direct product of glutamine degradation and maintaining the glutamine import sustains the import of cyst(e)ine, which has been related to increased therapy resistance in different cancer models [51], mostly due to its role in glutathione synthesis [52][53][54][55], for which glutamine-derived glutamate is also needed.…”
Section: Tca Cyclementioning
confidence: 99%
“…Riluzole interferes with glutamate flux and was shown to increase reactive oxygen species (ROS) by suppressing lactate dehydrogenase A (LDHA) and NAD+ [197]. Glutamate stimulates the glutamine import and glutaminolysis, sustaining the import of cyst(e)ine, which has been related to increased therapy resistance in different cancer models [51], mostly due to its role in glutathione synthesis [52,54]. Riluzole interferes with system xCT-cystine/glutamate antiporter, resulting in decreased GSH levels [197].…”
Section: New Therapies a Comprehensive Adjustment Of Therapy To The mentioning
confidence: 99%